Ticker Scorecard - CPRX Basics Company: Catalyst Pharmaceuticals, Inc. IPO Date: October 5, 2001 Sector: Healthcare Industry: Biotech Market Cap: $2.58B Activated in VL: True Average Daily Range Avg Daily Range: $0.13 | 3.31% Avg Daily Range (30 D): $0.42 | 2.00% Avg Daily Range (90 D): $0.36 | 1.70% Institutional Daily Volume Avg Daily Volume: .82M Avg Daily Volume (30 D): .82M Avg Daily Volume (90 D): .75M Trade Size Avg Trade Size (Sh.): 161 Avg Trade Size (Sh.) (30 D): 59 Avg Trade Size (Sh.) (90 D): 58 Institutional Trades Total Inst.Trades: 1,840 Avg Inst. Trade: $2.63M Avg Inst. Trade (30 D): $4.07M Avg Inst. Trade (90 D): $3.51M Avg Inst. Trade Volume: .23M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $3.22M Avg Closing Trade (30 D): $5.64M Avg Closing Trade (90 D): $4.83M Avg Closing Volume: 283.02K     News Jun 7, 2024 @ 3:30 PM Why Is Catalyst (CPRX) Up 0.7% Since Last Earnings... Source: Zacks Equity Research Jun 3, 2024 @ 1:00 PM A Closer Look at 7 Analyst Recommendations For Cat... Source: Benzinga Insights May 30, 2024 @ 5:41 PM Catalyst Pharmaceuticals Receives U.S. FDA Approva... Source: Catalyst Pharmaceuticals, Inc. May 28, 2024 @ 12:03 PM Catalyst Pharmaceuticals to Participate at the Jef... Source: Catalyst Pharmaceuticals, Inc. May 15, 2024 @ 12:00 PM 2 Incredible Growth Stocks to Buy Hand Over Fist R... Source: newsfeedback@fool.com (George Budwell) Financials   TTM Q3 2024 Q2 2024 Basic EPS $1.25 $.37 $.35 Diluted EPS $1.18 $.35 $.33 Revenue $ 460.48M $ 128.7M $ 122.71M Gross Profit $ 397.47M $ 109.42M $ 107.31M Net Income / Loss $ 142.8M $ 43.88M $ 40.79M Operating Income / Loss $ 173.97M $ 50.91M $ 54.25M Cost of Revenue $ 63.01M $ 19.28M $ 15.41M Net Cash Flow $ 321.36M $ 66.64M $ 65.28M PE Ratio 18.90